Douglas A. Greene

Epidemiological Correlates of Diabetic Neuropathy: Report From Pittsburgh Epidemiology of Diabetes Complications Study

Raelene E. Maser, Ann R. Steenkiste, Janice S. Dorman et al. · Diabetes · 1989 · 373 citations

Neuropathy Among the Diabetes Control and Complications Trial Cohort 8 Years After Trial Completion

Catherine L. Martin, James W. Albers, William H. Herman et al. · Diabetes Care · 2006 · 347 citations · Full text

Regeneration and Repair of Myelinated Fibers in Sural-Nerve Biopsy Specimens from Patients with Diabetic Neuropathy Treated with Sorbinil

Anders A. F. Sima, Vera Bril, Virgil Nathaniel et al. · New England Journal of Medicine · 1988 · 294 citations

A Diabetes Outcome Progression Trial (ADOPT)

Giancarlo Viberti, Steven E. Kahn, Douglas A. Greene et al. · Diabetes Care · 2002 · 269 citations · Full text

An aldose reductase inhibitor reverses early diabetes‐induced changes in peripheral nerve function, metabolism, and antioxidative defense

Irina G. Obrosova, Carol Van Huysen, Lamia Fathallah et al. · The FASEB Journal · 2001 · 209 citations · Full text

Peripheral Nerve Function, Insulin Signaling, Oxidative Stress +19